Use of Tolvaptan in pediatric SIADH associated hyponatremia: A case report
Journal of Pediatric Critical Care · 2026-05 · 13 (3) · 193-195
DOI: 10.4103/jpcc.jpcc_118_25 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Pediatric Critical Care, online erschienen am 19.06.2026. Verfasst von Sonam Agrawal und 3 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Hyponatremia is a common electrolyte abnormality in pediatric patients, often associated with infections and central nervous system pathology. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a frequent cause. We describe the case of a 2-year-old girl with meningoencephalitis who developed symptomatic refractory hyponatremia. Despite conventional management, the patient continued to experience recurrent seizures associated with low sodium levels. We used fractional excretion of uric acid (FeUA) to diagnose SIADH and used Tolvaptan for management. FeUA can be utilized to diagnose SIADH and Tolvaptan may be considered a safe and effective treatment for SIADH-related hyponatremia in selected pediatric patients.
Zitieren
APA
Agrawal, S., Kumar, R., Simalti, A., & Kalra, S. (2026). Use of Tolvaptan in pediatric SIADH associated hyponatremia: A case report. Journal of Pediatric Critical Care, 13(3), 193-195. https://doi.org/10.4103/jpcc.jpcc_118_25
Vancouver
Agrawal S, Kumar R, Simalti A, Kalra S. Use of Tolvaptan in pediatric SIADH associated hyponatremia: A case report. Journal of Pediatric Critical Care. 2026;13(3):193-195. doi:10.4103/jpcc.jpcc_118_25
BibTeX
@article{Agrawal2026,
author = {Agrawal, Sonam and Kumar, Rakesh and Simalti, Ashish and Kalra, Suprita},
title = {Use of Tolvaptan in pediatric SIADH associated hyponatremia: A case report},
journal = {Journal of Pediatric Critical Care},
year = {2026},
volume = {13},
number = {3},
pages = {193--195},
doi = {10.4103/jpcc.jpcc_118_25}
}
EUVIMED